Home > Insider Trading > Filing (0001181431-13-065072)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1114220	Keryx Biopharmaceuticals Inc	KERX	Pharmaceutical Preparations (2834)	134087132

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1434718	Iii F James Oliviero	C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2013-12-27	30,000	$12.68	525,929	No	4	S	Direct
Common Stock	Disposition	2013-12-30	49,500	$12.62	476,429	No	4	S	Direct
Common Stock (Exercise Of Stock Options)	Acquisiton	2013-12-30	30,000	$4.59	506,429	No	4	M	Direct
Common Stock	Disposition	2013-12-30	30,000	$12.64	476,429	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Footnotes

Sale of a total of 79,500 shares of common stock was made in order to satisfy Mr. Oliviero's income tax withholding obligation upon the vesting of 150,000 shares of restricted stock on a corporate milestone. Such sale was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
Reflects the weighted average sale price. The range of prices for such transaction is $12.65 to $12.82.
Includes 296,537 shares of restricted stock.
Reflects the weighted average sale price. The range of prices for such transaction is $12.60 to $12.72.
Reflects the exercise and sale of 30,000 stock options which were due to expire on January 2, 2014 (10 years following their grant date).
Reflects the weighted average sale price. The range of prices for such transaction is $12.60 to $12.74.
Following the transactions reported on this Form 4, Mr. Oliviero holds 476,429 shares of Keryx common stock (of which 296,537 are restricted shares) and 327,616 stock options.